Suppr超能文献

然后只剩下三个:移植前透析对多器官移植的影响。

And Then There Were Three: Effects of Pretransplant Dialysis on Multiorgan Transplantation.

作者信息

Cheng Xingxing S, Han Jialin, Stedman Margaret R, Chertow Glenn M, Tan Jane C

机构信息

Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA.

出版信息

Transplant Direct. 2021 Jan 15;7(2):e657. doi: 10.1097/TXD.0000000000001112. eCollection 2021 Feb.

Abstract

BACKGROUND

Simultaneous liver-kidney (SLK) and simultaneous heart-kidney (SHK) transplantation currently utilize 6% of deceased donor kidneys in the United States. To what extent residual kidney function accounts for apparent kidney allograft survival is unknown.

METHODS

We examined all adult SLK and SHK transplants in the United States during 1995-2014. We considered the duration of dialysis preceding SLK or SHK (≥90 d, 1-89 d, or none) as a proxy of residual kidney function. We used multinomial logistic regression to estimate the difference in the adjusted likelihood of 6- and 12-month apparent kidney allograft failure between the no dialysis versus ≥90 days dialysis groups.

RESULTS

Of 4875 SLK and 848 SHK recipients, 1775 (36%) SLK and 449 (53%) SHK recipients received no dialysis before transplant. The likelihood of apparent kidney allograft failure was 1%-3% lower at 12 months in SLK and SHK recipients who did not require pretransplant dialysis relative to recipients who required ≥90 days of pretransplant dialysis. Among 3978 SLK recipients who survived to 1 year, no pretransplant dialysis was associated with a lower risk of apparent kidney allograft failure over a median follow-up of 5.7 years (adjusted hazard ratio 0.73 [0.55-0.96]).

CONCLUSIONS

Patients with residual kidney function at the time of multiorgan transplantation are less likely to have apparent failure of the kidney allograft. Whether residual kidney function facilitates function of the allograft or whether some SLK and SHK recipients have 3 functional kidneys is unknown. Sustained kidney function after SLK and SHK transplants does not necessarily indicate successful MOT.

摘要

背景

在美国,肝肾联合移植(SLK)和心肾联合移植(SHK)目前使用了6%的已故捐赠者肾脏。残余肾功能在多大程度上导致了肾移植的明显存活情况尚不清楚。

方法

我们研究了1995年至2014年期间美国所有成人SLK和SHK移植病例。我们将SLK或SHK之前的透析时间(≥90天、1 - 89天或无透析)作为残余肾功能的替代指标。我们使用多项逻辑回归来估计无透析组与透析≥90天组在6个月和12个月时肾移植明显失败的调整后可能性差异。

结果

在4875名SLK受者和848名SHK受者中,1775名(36%)SLK受者和449名(53%)SHK受者在移植前未接受透析。与需要≥90天移植前透析的受者相比,在移植前不需要透析的SLK和SHK受者中,肾移植明显失败的可能性在12个月时低1% - 3%。在3978名存活至1年的SLK受者中,移植前无透析与肾移植明显失败风险较低相关,中位随访时间为5.7年(调整后风险比0.73 [0.55 - 0.96])。

结论

多器官移植时具有残余肾功能的患者肾移植明显失败的可能性较小。残余肾功能是促进了移植肾的功能,还是部分SLK和SHK受者有三个功能正常的肾脏尚不清楚。SLK和SHK移植后的持续肾功能不一定表明多器官移植成功。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177f/7817305/64983f9a4e5c/txd-7-e657-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验